Cost-Effectiveness Of Midostaurin In The Treatment Of Acute Myeloid Leukemia With The FLT3 Mutation In Spain

PURPOSE: The addition of midostaurin to standard chemotherapy (cytarabine and daunorubicin) has shown significant improvements in the survival of patients with acute myeloid leukemia with the FLT3 mutation (FLT3-AML). The objective of this study was to determine whether this intervention would be co...

Descripción completa

Detalles Bibliográficos
Autores principales: Arenaza, Ainhoa, Diez, Raúl, Esteve, Jordi, Di Nicolantonio, Roberta, Gostkorzewicz, Joana, Martínez, Carlos, Martínez Llinàs, Diana, Martinez-Lopez, Joaquin, Montesinos, Pau, Moure-Fernández, Aída, Sierra, Jorge, Vinent, Joan Lluís
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859089/
https://www.ncbi.nlm.nih.gov/pubmed/32009807
http://dx.doi.org/10.2147/CEOR.S222879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859089/
https://www.ncbi.nlm.nih.gov/pubmed/32009807
http://dx.doi.org/10.2147/CEOR.S222879

Ejemplares similares